PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 14, 2026Ecotoxicology and Environmental Safety2 citationsOpen Access

Environmental flame retardant EHDPP stabilizes EGFR to accelerate lung cancer progression: Integrated network toxicology, bioinformatics, and in vitro evidence

View Full Paper
KDKun DingLBLonglong BaiWLWenzhen Liu

Key Points

  • This study aims to investigate the molecular mechanisms by which EHDPP promotes lung cancer progression.
  • Utilized toxicity prediction platforms to assess potential hazards of EHDPP.
  • Conducted multi-database screening to identify targets related to EHDPP-induced lung cancer.
  • Performed pathway analyses and identified core targets using STRING and Cytoscape.
  • Analyzed gene expression data and conducted molecular docking and in vitro experiments.
  • Identified 355 potential targets linked to EHDPP-induced lung cancer.
  • Key pathways involved include cell migration regulation and the PI3K-AKT signaling pathway.
  • Confirmed binding interactions between EHDPP and EGFR, enhancing EGFR stability.
  • Demonstrated that EHDPP significantly promotes lung cancer cell proliferation and migration.

Abstract

As a typical organophosphate flame retardant, 2-ethylhexyl diphenyl phosphate (EHDPP) is widely present in the environment through inhalation exposure, but its mechanism in promoting lung cancer progression remains unclear. This study integrates network toxicology, molecular docking, tumor bioinformatics analysis, and in vitro cell models to systematically investigate the molecular carcinogenic network of EHDPP. First, the potential toxicity of EHDPP was predicted using PROTox and ADMETlab toxicity prediction platforms. Multi-database integration and screening identified 355 potential targets associated with EHDPP-induced lung cancer. KEGG pathway and GO functional enrichment analyses revealed that these key genes were significantly enriched in positive regulation of cell migration, metabolic pathways, and the PI3K-AKT signaling pathway. Further analysis using STRING and Cytoscape software identified 20 core targets, including MAPK14, AKT1, RXRA, PTK2, PTPN11, and EGFR. By integrating core gene expression and prognostic data, four genes-EGFR, RAC1, RXRA, and HRAS-were identified as key molecular hubs potentially regulating EHDPP-driven malignant phenotypes in lung cancer. Analysis of publicly available scRNA-seq data revealed high expression of these four hub genes in immune-related cells as well as AT2 cells, suggesting their potential roles in lung cancer. Molecular docking confirmed moderate predicted binding affinity, suggesting potential interactions between EHDPP and core targets. Additionally, cell model experiments demonstrated that EHDPP significantly promotes the proliferation and migration of lung cancer cells via the PI3K-AKT signaling pathway. Mechanistically, EHDPP binds to EGFR and inhibits its ubiquitination-mediated degradation, thereby stabilizing EGFR protein and partly activating the downstream PI3K-AKT signaling pathway, which ultimately promotes lung cancer cell proliferation and migration. This study is the first to elucidate the molecular mechanism underlying the pro-carcinogenic effects of EHDPP at the interaction level, providing potential molecular marker clues and mechanistic basis for EHDPP-related environmental risk assessment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ding et al. (2026) studied this question.

synapsesocial.com/papers/699010382ccff479cfe56cf7https://doi.org/10.1016/j.ecoenv.2026.119854
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pericytes recruited by CCL28 promote vascular normalization after anti-angiogenesis therapy through RA/RXRA/ANGPT1 pathway in lung adenocarcinoma2024 · 14 citations
  2. 2The Role of Human Adiponectin Receptor 1 in 2-Ethylhexyl Diphenyl Phosphate Induced Lipid Metabolic Disruption2024 · 2 citations
  3. 3Epidermal growth factor receptor (EGFR) is a target of the tumor-suppressor E3 ligase FBXW72024 · 30 citations
  4. 4SERPINE2 promotes liver cancer metastasis by inhibiting c‐Cbl‐mediated EGFR ubiquitination and degradation2024 · 46 citations
  5. 5The risk and impact of organophosphate esters on the development of female-specific cancers: Comparative analysis of patients with benign and malignant tumors2020 · 70 citations